Advertisement
Evotec, Novo Nordisk Roll Out LAB EN To Accelerate Translation In Cardiometabolic Diseases
(RTTNews) - Evotec SE (EVO, EVOTF.PK) and Novo Nordisk A/S (NVO) announced Tuesday a translational drug discovery accelerator called LAB eN, which aims to nurture early research from academic institutions into novel therapeutics.
LAB eN is a unique engagement model that combines Evotec's multimodality drug discovery and pre-clinical development capabilities with Novo Nordisk's therapeutic, clinical, and commercial expertise.
LAB eN will focus on addressing unmet need in cardiometabolic diseases as well as rare blood and rare endocrine disorders.
LAB eN has already signed on four academic institutions to participate: Harvard University, Mass General Brigham, Yale University, and Beth Israel Deaconess Medical Center.
read more
Novo Nordisk Stock Climbs On Higher Q1 Results; Cuts FY25 Outlook
Shares of Novo Nordisk A/S were gaining around 6 percent in Denmark as well as around 7 percent in the pre-market activity on the NYSE, after the Danish drug major reported Wednesday higher profit and sales in its first quarter, mainly reflecting improved results of its blockbuster weight loss drug Wegovy. Meanwhile, the company trimmed fiscal 2025 outlook for sales and operating profit growth...
RTTNews
|
vor 7 Tagen
Novo Nordisk Plans $4.1 Bln NC Facility To Boost Obesity Drug Supply
Danish drug maker Novo Nordisk announced its plans to invest $4.1 billion or about 27 billion Danish kroner to build a new manufacturing plant in Clayton, North Carolina with a view to expanding its manufacturing capacity in the United States. In the new plant, the company plans to produce current and future injectable treatments for people with obesity and other serious chronic diseases.
RTTNews
|
vor 323 Tagen
Novo Nordisk Says FLOW Trial Achieves Primary Endpoint
Novo Nordisk A/S (NVO) announced Tuesday the headline results from the kidney outcomes trial FLOW. The announcement follows the decision to stop the trial early due to efficacy.
RTTNews
|
vor 435 Tagen
Novo Nordisk Slashes US List Prices Of Several Insulin Products By Up To 75%
Healthcare company Novo Nordisk Inc. (NVO) announced Tuesday it is lowering the U.S. list prices of several pre-filled insulin pens and vials by up to 75% for people living with type 1 and type 2 diabetes.
RTTNews
|
vor 792 Tagen
Japanese Market Significantly Lower
The Japanese market is trading significantly lower on Thursday, extending the losses in the previous session, following the mixed cues from Wall Street overnight. The Nikkei 225 is falling below the 37,800 level, with weakness across most sectors led by index heavyweights, automakers and technology stocks.
RTTNews
|
vor 5 Minuten
Indonesia Bourse May Test Resistance At 7,000 Points
The Indonesia stock market has finished higher in two straight sessions, improving more than 150 points or 2.2 percent in that span. The Jakarta Composite Index now rests just beneath the 6,980-point plateau although investors may lock in gains on Thursday.
RTTNews
|
vor 14 Minuten
Oversold Hang Seng Nonetheless Called Higher Again
The Hong Kong stock market bounced higher again on Wednesday, one day after snapping the eight-day winning streak in which it had surged almost 1,600 points or 7.1 percent. The Hang Seng Index now sits just above the 23,640-point plateau although it may tick higher again on Thursday.
RTTNews
|
vor 29 Minuten
Australian Market Slightly Lower
The Australian market is trading slightly lower on Thursday, snapping a six-session winning streak, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying well below the 8,300 level, with weakness across most sectors led by gold miners and energy stocks.
RTTNews
|
vor 30 Minuten
